Clinicopathologic and genomic characteristics of patients with advanced ovarian, breast, and prostate cancer treated with poly (ADP-ribose) polymerase inhibitors (PARPi) in a real-world setting

被引:0
作者
Velimirovic, Marko
Kuzmanovic, Teodora
Nikoo, Maedeh Zokaei
Brihn, Lesil
Konig, Vicky
Watson, Tejuana
Austin, Teana
Bokovitz, Lauren
Behera, Tapas Ranjan
Savage, Gabriel
Kilbane, Megan
Azzato, Elizabeth M.
Tu, Zheng Jin
Ma, Wen Wee
Vargas, Roberto
Miller, Jacob
Yilmaz, Emrullah
Ni, Ying
机构
[1] Cleveland Clin, Cleveland, OH USA
[2] Cleveland Clin, Taussig Canc Ctr, Cleveland, OH USA
[3] Cleveland Clin Fdn, Cleveland, OH USA
[4] Cleveland Clin Brunswick Urgent Care, Cleveland, OH USA
[5] Cleveland Clin, Ctr Immunotherapy & Precis Immuno Oncol, Cleveland, OH USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3159
引用
收藏
页数:1
相关论文
empty
未找到相关数据